Macrophage phenotype in mice deficient in both macrophage-colony- stimulating factor (Op) and apolipoprotein E

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 18, Issue 4, 1998, Pages 631-640

  De Villiers, Willem J S ^a,c   Smith, Jonathan D ^b   Miyata, Masaaki ^b   Dansky, Hayes M ^b   Darley, Elizabeth ^a   Gordon, Siamon ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b ROCKEFELLER UNIVERSITY   (United States)

^c UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

Apolipoprotein E; Atherosclerosis; Macrophage colony stimulating factor; Macrophages

Indexed keywords

COLONY STIMULATING FACTOR 1;

ANIMAL EXPERIMENT; ARTICLE; ATHEROSCLEROSIS; DISEASE ASSOCIATION; GENETIC HETEROGENEITY; HYPERCHOLESTEROLEMIA; HYPERLIPOPROTEINEMIA TYPE 3; LIPID STORAGE; LIVER SINUSOID; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL;

EID: 0031977846     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.18.4.631     Document Type: Article

References (25)

1. Ross R. The pathogenesis of atherosclerosis; a perspective for the 1990s. Nature. 1993;362:801-809.
2. Plump AS, Smith JD, Hayek T, Aalto-Setala K. Walsh A, Verstuyft JG, Rubin EM, Breslow JL. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell. 1992;71:343-353.
3. Reddick RL, Zhang SH, Maeda N. Atherosclerosis in mice lacking apoE: evaluation of lesional development and progression. Arterioscler Thromb. 1994;14:141-147.
4. Nakashima Y, Plump AS, Raines EW, Breslow JL, Ross R. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb. 1994;14:133-140.
5. Motoyoshi K, Takaku F. Serum cholesterol-lowering activity of human monocytic colony-stimulating factor. Lancet. 1989;2:326-327.
6. Stoudemire JB, Garnick MB. Effects of recombinant macrophage-colony stimulating factor on plasma cholesterol levels. Blood. 1991;77:750-755.
7. Schaub RG, Bree MP, Hayes LL, Rudd MA, Rabbani L, Loscalzo J, Clinton SK. Recombinant human macrophage-colony stimulating factor reduces plasma cholesterol and carrageenan granuloma foam cell formation in Watanabe heritable hyperlipidemic rabbits. Arterioscler Thromb. 1994;14:70-76.
8. Inoue I, Inaba T, Motoyoshi K, Harada K, Shimano H, Kawamura M, Gotoda T, Oka T, Shiomi M, Watanabe Y, Tsukuda T, Yazaki Y, Tafaku F, Yamada N. Macrophage colony stimulating factor prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits. Atherosclerosis. 1992;93:245-254.
9. Krieger M, Herz J. Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu Rev Biochem. 1994;63:601-637.
10. Suzuki H, Kurihara Y, Takeya M, Kamada N, Kataoka M, Jishage K, Ueda O, Sakaguchi H, Higashi T, Suzuki T, Takashima Y, Kawabe Y, Cynshi O, Wada Y, Honda M, Kurihara H, Aburatani H, Doi T, Matsumoto A, Azuma S, Noda T, Toyoda Y, Itakura H, Yazaki Y, Horiuchi S, Takahashi K, Kruijt JK, van Berkel TJC, Steinbrecher UP, Ishibashi S, Maeda N, Gordon S, Kodama T. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection Nature. 1997;386:292-296.
11. de Villiers WJS, Fraser IP, Hughes DA, Doyle AC, Gordon S. Macrophage-colony-stimulating factor selectively enhances macrophage scavenger receptor expression and function. J Exp Med 1994;180:705-709.
12. Wiktor-Jedrzejczak W, Bartocci A, Ferrante AW, Ahmed-Ansari A, Sell KW, Pollard JW, Stanley ER. Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse. Proc Natl Acad Sci USA. 1990;87:4828-4832.
13. Witmer-Pack MD, Hughes DA, Schuler G, Lawson L. McWilliam A, Inaba K, Steinman RM, Gordon S. Identification of macrophages and dendritic cells in the osteopetrotic (op/op) mouse. J Cell Sci. 1993;104:1021-1029.
14. Wiktor-Jedrzejczak W, Gordon S. Cytokine regulation of the macrophage (op/op) mouse. Physiol Rev. 1996;76:927-947.
15. Yoshida H, Hayashi S-I, Kunisada T, Ogawa M, Nishikawa S, Okamura H, Sudo T, Shultz LD, Nishikawa S-I. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature. 1990;345:442-444.
16. Kodama H, Nose M, Niida S, Yamasaki A. Essential role of macrophage colony-stimulating factor in the osteoclast differentiation supported by stromal cells. J Exp Med. 1991;173:1291-1294.
17. Wiktor-Jedrzejczak W, Ahmed A, Szczylik C, Skelly RR. Hematologic characterization of congenital osteopetrosis in op/op mouse: possible mechanism for abnormal macrophage differentiation. J Exp Med. 1982;156:1516-1527.
18. Smith JD, Trogan E, Ginsberg M, Grigaux C, Tian J, Miyata M. Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E. Proc Natl Acad Sci USA. 1995;92:8264-8268.
19. Qiao J-H, Tripathi J, Mishra NK, Cai Y, Tripathi S, Wang X-P, Imes S, Fishbein MC, Clinton SK, Libby P, Lusis AJ, Rajavashisth TB. Role of macrophage colony-stimulating factor in atherosclerosis: studies in osteopetrotic mice. Am J Pathol. 1997;150:1687-1699.
20. Austyn JM, Gordon S. F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur J Immunol. 1981;11:805-815.
21. Smith MJ, Koch GLE. Differential expression of murine macrophage surface glycoprotein antigens in intracellular membranes. J Cell Sci. 1987;87:113-119.
22. Rosen H, Gordon S. Monoclonal antibody to the murine type 3 complement receptor inhibits adhesion of myelomonocytic cells in vitro and inflammatory cell recruitment in vivo. J Exp Med. 1987;166:1685-1701.
23. Fraser I, Hughes D, Gordon S. Divalent cation-independent macrophage adhesion inhibited by monoclonal antibody to murine scavenger receptor. Nature. 1993;364:343-346.
24. van den Berg TK, Breve JJ, Damoiseaux JG, Dopp EA, Kelm S, Crocker PR, Dijkstra CD, Kraal G. Sialoadhesin on macrophages: its identification as a lymphocyte adhesion molecule. J Exp Med. 1992;176:647-655.
25. Unkeless JC. Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. J Exp Med. 1979;150:580-596.